Arizona Targets Purdue in Opioid Crisis Suit Filed Straight to Supreme Court

Family and friends who have lost loved ones to OxyContin and opioid overdoses leave protest messages written on pill bottles outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Conn.

Family and friends who have lost loved ones to OxyContin and opioid overdoses leave protest messages written on pill bottles outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Conn. AP Photo

 

Connecting state and local government leaders

STATE AND LOCAL ROUNDUP | Reform school abuse in Pennsylvania … Ignored police body cam policy in Chicago …Considering a casino deal in Connecticut.

Surveying a national legal landscape already dotted with thousands of cases targeting Purdue Pharma as the main corporate culprit in the country’s opioid crisis, Arizona Attorney General Mark Brnovich on Wednesday filed a lawsuit directly to the nation’s top court. Brnovich told the New York Times that filing the suit, which specifically is aimed at the Sackler family that owns Purdue, straight to the Supreme Court was an “unorthodox” tactic that carried “long-shot” odds of success. But Brnovich said he felt justified in making the move when weighing the gravity of the opioid crisis and the pressing need for compensation, on one side, against the backlog of suits already filed targeting Purdue and the vast amounts of money at stake on the other. “Absent resolution in a single forum, these disputes will be fought over and over in nearly every state in the nation,” the Arizona lawsuit argues. “This is likely to take years, lead to inconsistent judgments and create an inequitable distribution of money damages.”  A federal court in Cleveland is already seeking to resolve some 2,000 lawsuits brought by cities, counties and Native American tribes filed against “key players in the opioid crisis,” the Times reported. The Arizona suit accuses the Sackler family, which owns Purdue, of “looting” the company through “illegal transfers” of $4 billion in order to avoid losing that money in lawsuits seeking compensation. A spokesman for the Sackler family said the claims are “inconsistent with the factual record.” Purdue is estimated to have earned more than $30 billion in OxyContin sales. So far, it has paid out $600 million in federal fines and distributed $19.5 million to 26 states, including Arizona, to settle a 2007 lawsuit that detailed the aggressive marketing techniques the company used to sell the drug despite the grave danger it posed to public health. Brnovich said opioid-related deaths in Arizona have risen 76 percent since 2013. He said the Arizona health department has estimated that between June 2017 and June 2019 more than 3,000 Arizonans died from opioid overdose. [New York Times, Arizona Daily Star]

ABUSE | In the wake of horrific revelations of abuse at Glen Mills reform school in Delaware County, Pennsylvania Governor Tom Wolf issued an executive order directing the state to remake the system that oversees juvenile residential programs. “Today is a day of reckoning,” he said Wednesday, after signing the order. “Today, we are being honest that the decades-in-making, outdated, rigid, convoluted system is not working for too many Pennsylvanians.”  An investigation by the Philadelphia Inquirer published in February found that counselors at Glen Mills beat children violently, sometimes breaking their bones, and coerced them into lying about their injuries. The state Department of Human Services in April revoked the schools operating licenses. Wolf said he will pursue “extensive regulatory and legislative actions with input from the General Assembly.” His executive order creates a Council on Reform to make policy recommendations, an Office of Advocacy and Reform and a new Child Advocate to “act as an ombudsman for youth in the state’s facilities,” according to the Inquirer. Glen Mills was founded in 1826 as the Philadelphia House of Refuge and is the oldest existing reform school in the country. [Philadelphia Inquirer, AP]

POLICE VIDEO | Chicago police are failing to properly record and review video from officer body cameras, the city’s inspector general has found. A report issued by the inspector this week found officers often failed to wear or turn on their cameras and that commanders were inconsistent in reviewing body camera use and footage, even though the city received $2.2 million from city taxpayers to ensure the city’s police properly carried out the video program. “We’ll be handling this internally to make sure that it gets done and that there’s a level of accountability for those who fail to fulfill their obligations to do those inspections,” Mayor Lori Lightfoot told reporters. “For those individuals who weren’t in compliance, then there will be some accountability with them,” said Police Superintendent Eddie JohnsonJohnson. [2 CBS]

GAMBLING | Connecticut lawmakers have inched closer to green-lighting a Bridgeport tribal casino resort project. But Governor Ned Lamont has yet to support the deal, which he says he thinks falls short of the mark, and MGM Resorts, which has eyed Bridgeport for its own casino project, may sue, reports the Hartford Courant. Lamont said he is seeking a “global resolution that mitigates the likelihood of years of litigation and that positions the state to capitalize on a comprehensive gaming platform.” The proposed legislation would allow the state lottery to offer online ticket sales and the Mohegan and Mashantucket Pequot tribes—two of the state’s largest employers—to provide internet gambling and conduct casino sports betting through mobile apps. Sports betting would be taxed at 8%; internet gambling at 10%. Supporters of the bill have requested the governor to launch a special session of the Legislature in the fall to take up the measure. [Hartford Courant, Fox61]

URBAN MENTAL HEALTH | A team of scholars headed by professors at the University of Washington and Stanford recently published a framework they hope city officials might use to begin to measure the mental health benefits of nature with an eye to incorporating their findings into city policy and planning. “We have entered the urban century, with two-thirds of humanity projected to be living in cities by 2050,” said senior author Gretchen Daily, faculty director at the Stanford Natural Capital Project. “At the same time, there is an awakening underway today to the many values of nature and the risks and costs of its loss.” The study is available here. [Science Advances, UW News]

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.